Macrogenics (MGNX) Other Accumulated Expenses (2013 - 2019)
Macrogenics (MGNX) reported Other Accumulated Expenses of $175000.0 for Q3 2019, little changed year-over-year from $175000.0 in Q3 2018, and little changed quarter-over-quarter from $175000.0 in Q2 2019.
Macrogenics (MGNX) Other Accumulated Expenses (2013 - 2019) Analysis & Trends
Macrogenics (MGNX) has 6 years of Other Accumulated Expenses data on file, last reported at $175000.0 in Q3 2019.
- Other Accumulated Expenses for Q3 2019 came in at $175000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Sep 2019 was $175000.0 (changed 0.0% YoY), and the FY2018 annual result was $175000.0, down 63.0% from the prior year.
- Other Accumulated Expenses steadied at $175000.0 in Q3 2019 per MGNX's latest filing, from $175000.0 in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $1.6 million in Q1 2015 and troughed at $175000.0 in Q3 2017.
- A 4-year average of $570384.6 and a median of $175000.0 in 2017 frame the typical range for Other Accumulated Expenses.
- The sharpest annual moves came in 2015 and 2018: Other Accumulated Expenses surged 342.25% in 2015, then sank 63.0% in 2018.
- A 4-year view of Other Accumulated Expenses shows it stood at $727000.0 in 2015, then plunged by 34.94% to $473000.0 in 2017, then slumped by 63.0% to $175000.0 in 2018, then changed by 0.0% to $175000.0 in 2019.
- Business Quant data shows MGNX's Other Accumulated Expenses at $175000.0 in Q3 2019, $175000.0 in Q2 2019, and $175000.0 in Q1 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Macrogenics | 260.14 Mn | 193.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 175,000.00 |
| Jun 30, 2019 | 175,000.00 |
| Mar 31, 2019 | 175,000.00 |
| Dec 31, 2018 | 175,000.00 |
| Sep 30, 2018 | 175,000.00 |
| Jun 30, 2018 | 175,000.00 |
| Mar 31, 2018 | 175,000.00 |
| Dec 31, 2017 | 473,000.00 |
| Sep 30, 2017 | 175,000.00 |
| Dec 31, 2015 | 727,000.00 |
| Sep 30, 2015 | 1.61 Mn |
| Jun 30, 2015 | 1.61 Mn |
| Mar 31, 2015 | 1.61 Mn |
| Dec 31, 2014 | 1.61 Mn |
| Sep 30, 2014 | 363,000.00 |
| Jun 30, 2014 | 363,000.00 |
| Mar 31, 2014 | 362,920.00 |
| Dec 31, 2013 | 363,000.00 |